论文部分内容阅读
目的观察丹红注射液与低分子肝素钙联用治疗不稳定型心绞痛(UA)的临床疗效。方法将患者随机分为治疗组和对照组,两组均予常规治疗,治疗组采用丹红注射液静脉滴注及低分子肝素钙皮下注射,对照组给予复方丹参液静脉滴注及低分子肝素钙皮下注射。结果治疗组总有效率为96.8%;对照组为88.7%,两组比较有统计学意义(P<0.05)。结论丹红注射液联用低分子肝素钙治疗不稳定型心绞痛疗效优于复方丹参液及低分子肝素钙。
Objective To observe the clinical efficacy of Danhong injection combined with low molecular weight heparin in the treatment of unstable angina pectoris (UA). Methods The patients were randomly divided into treatment group and control group. Both groups were given conventional treatment. The treatment group received intravenous infusion of Danhong injection and subcutaneous injection of low molecular weight heparin, while the control group received intravenous infusion of compound Danshen liquid and low molecular weight heparin Calcium subcutaneous injection. Results The total effective rate was 96.8% in the treatment group and 88.7% in the control group, with statistical significance (P <0.05). Conclusion Danhong injection combined with low molecular weight heparin calcium in the treatment of unstable angina pectoris is superior to compound Danshen liquid and low molecular weight heparin calcium.